BioTransplant's Other Investors

BioTransplant raised a round of funding on , .

BioTransplant (BT) acquired Eligix, a developer of therapy for patients receiving bone marrow (or stem cell) transplants and related procedures to treat leukemia, lymphoma, and other diseases,…

Articles about BioTransplant's Other Investors: